Charles Schwab
ETON icon

Charles Schwab’s Eton Pharmaceutcials ETON Stock Holding History

Charles Schwab’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
77,032
+8,237
+12% +$242K ﹤0.01% 2677
2026
Q1 		$1.7M Sell
68,795
-8,417
-11% -$147K ﹤0.01% 2757
2025
Q4 		$1.31M Sell
77,212
-62
-0.1% -$1.09K ﹤0.01% 2842
2025
Q3 		$1.68M Sell
77,274
-574
-0.7% -$9.53K ﹤0.01% 2794
2025
Q2 		$1.11M Buy
77,848
+64,601
+488% +$1.02M ﹤0.01% 2866
2025
Q1 		$172K Buy
13,247
+8
+0.1% +$121 ﹤0.01% 3276
2024
Q4 		$176K Hold
13,239
– – ﹤0.01% 3344
2024
Q3 		$79.4K Hold
13,239
– – ﹤0.01% 3388
2024
Q2 		$43.6K Hold
13,239
– – ﹤0.01% 3524
2024
Q1 		$49.6K Hold
13,239
– – ﹤0.01% 3370
2023
Q4 		$58K Hold
13,239
– – ﹤0.01% 3391
2023
Q3 		$55.2K Hold
13,239
– – ﹤0.01% 3399
2023
Q2 		$46.2K Hold
13,239
– – ﹤0.01% 3429
2023
Q1 		$51K Hold
13,239
– – ﹤0.01% 3344
2022
Q4 		$37.1K Hold
13,239
– – ﹤0.01% 3418
2022
Q3 		$28K Hold
13,239
– – ﹤0.01% 3446
2022
Q2 		$35K Buy
+13,239
New +$44.4K ﹤0.01% 3444
2021
Q2 		– Sell
-41,409
Closed -$304K – 3454
2021
Q1 		$304K Hold
41,409
– – ﹤0.01% 3238
2020
Q4 		$337K Buy
41,409
+6,141
+17% +$47.4K ﹤0.01% 3114
2020
Q3 		$279K Sell
35,268
-13,209
-27% -$90.2K ﹤0.01% 3054
2020
Q2 		$265K Buy
+48,477
New +$241K ﹤0.01% 3098

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Charles Schwab's ETON Position: Q2 2026 in Review

Charles Schwab increased its Eton Pharmaceutcials (ETON) stake by 12% in Q2 2026, buying an estimated $242K and bringing the position to 77,032 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2677.

Charles Schwab first reported a position in ETON in Q2 2020 and has held it in 21 quarters since. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Charles Schwab held 77,032 shares of Eton Pharmaceutcials worth $2.79M as of Q2 2026.
  • Charles Schwab bought 8,237 Eton Pharmaceutcials shares in Q2 2026, an estimated $242K.
  • Eton Pharmaceutcials made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2677 holding.
  • Charles Schwab first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 21 quarters since.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.